BiOS was officially launched on 10 February 2005 by Cambia, an independent, international non-profit organization dedicated to democratizing innovation.
[1] As described by Richard Anthony Jefferson, CEO of Cambia, the Deputy CEO of Cambia, Dr Marie Connett worked extensively with small companies, university offices of technology transfer, attorneys, and multinational corporations to create a platform to share productive and sustainable technology.
To be granted full, unfettered commercial rights to listed technologies, licensees are required to comply with three conditions: As with other legal instruments, definitions used in the BiOS licenses are important.
The scope and core capabilities of the enabling technologies and platforms should be carefully defined to provide confidence in the development of viable business models surrounding the use of the BiOS license.
[7] CambiaLabs[8] engineered two ‘open source’ biological technologies, TransBacter and GUSPlus,[9] which they released under the BiOS Initiative.